Buda Juice, Inc. (BUDA) stock analysis
Close on Nov 11, 2026Market cap $90.48MP/E 36.0Yield –
StockData Score
Prices as of Nov 11, 2026How the score works
Weak8 of 30 checks passed
Buda Juice passes 8 of the 30 checks behind our score; 16 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 0/6
- Growth
- 1/6
- Past performance
- 3/6
- Financial health
- 4/6
- Dividend
- 0/6
What stands out
Return on capital over 10%
Return on invested capital was 113%, above the 10% that usually covers the cost of capital.
Low debt
Debt is 3.5% of shareholders' equity, under the 40% we consider low.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 417% of total debt.
Low bankruptcy risk
The Altman Z-score is 27.13; above 3 is the safe zone and below 1.8 the distress zone.
What to watch
Margin of safety under 20%
The price is 27.9% above fair value, so there is no margin of safety.
Trading above fair value
The share price of $7.20 is above our fair value estimate of $5.63.
P/E above the industry
Buda Juice's P/E of 36.0 is above the Beverages median of 32.8.
P/B above the industry
Buda Juice's price-to-book of 4.18 is above the Beverages median of 2.94.
Valuation0/6
P/E against its history
Not enough price and earnings history to compare.
P/E above the industry
Buda Juice's P/E of 36.0 is above the Beverages median of 32.8.
EV/EBITDA against its history
Needs positive EBITDA and price history.
P/B above the industry
Buda Juice's price-to-book of 4.18 is above the Beverages median of 2.94.
Trading above fair value
The share price of $7.20 is above our fair value estimate of $5.63.
Margin of safety under 20%
The price is 27.9% above fair value, so there is no margin of safety.
Growth1/6
Revenue growth over 3 years
Needs three years of positive revenue.
EPS growth over 3 years
Needs positive EPS three years ago and today.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing faster than the industry
Revenue grew 11.8% over the last twelve months; the Beverages median is 4.5%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin slipping
Gross margin was 44.6% over the last twelve months, against 46.2% a year earlier.
Past performance3/6
Return on equity
Needs positive equity and five years of results.
Return on capital over 10%
Return on invested capital was 113%, above the 10% that usually covers the cost of capital.
Return on equity above the industry
Buda Juice's return on equity of 28.5% is above the Beverages median of 16.5%.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin against its history
Needs five years of revenue and net income.
Net margin above the industry
Buda Juice's net margin of 28.0% is above the Beverages median of 7.3%.
Financial health4/6
Low debt
Debt is 3.5% of shareholders' equity, under the 40% we consider low.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 417% of total debt.
Interest coverage
Interest expense is not reported separately.
Short-term assets cover short-term debts
Current assets are 15.21 times current liabilities.
Low bankruptcy risk
The Altman Z-score is 27.13; above 3 is the safe zone and below 1.8 the distress zone.
Dividend0/6
No dividend
Buda Juice has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itOur estimate per share
$5.63
The share price is 28% above this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 32.8× | – | 32.8× | $6.56 | 44% |
| EV/EBITDA | 15.0× | – | 15.0× | $5.84 | 39% |
| Earnings power | 9.9% cost of equity | – | – | $2.66 | 17% |
| Fair value | $5.63 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
High risk
- Average value traded per day
- $33.10K
- Value traded per 1% price move
- $10.60K
Downside
Medium risk
- Typical loss in a bad month
- 23.5%
- Volatility (annualized)
- 71%
- Sharpe ratio, 1 year
- -0.25
- Beta to the S&P 500 (5Y)
- –
Margins
Share of revenue, fiscal years 2023 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +11.8% | – | – | – | |
| Gross profit | +8.1% | – | – | – | |
| Operating income | +1.1% | – | – | – | |
| Net income | -1.1% | – | – | – | |
| EPS, diluted | 0.0% | – | – | – | |
| Free cash flow | -11.7% | – | – | – |
Returns and balance sheet
3 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2023 | FY2023 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | – | 102.5% | |
| Current ratio | – | – | 5.50 | |
| Capex to revenue | – | – | 2.0% | |
| Diluted shares | – | – | 0M |
Cash use needs five years of cash flow figures
Buda Juice does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 28.0% | 2.90× | 1.26× | 102.5% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$3.53M
- Cash generatingOperating cash flow above zero$3.15M
- Return on assets improvedROA up on the prior year– → 94.7%
- Earnings backed by cashOperating cash flow above net income$3.15M vs $3.53M
- Less leverageLong-term debt to assets fell– → 13.0%
- Better liquidityCurrent ratio rose4.69 → 5.50
- No dilutionShare count did not rise0M → 0M
- Gross margin improvedGross margin up on the prior year46.20% → 44.64%
- More efficientAsset turnover rose– → 3.38
See a number that looks wrong?